- Home
- DHR vs GSK Comparison
DHR vs GSK Comparison
Compare DHR & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DHR | GSK |
|---|---|---|
| Founded | 1969 | 1715 |
| Country | United States | United Kingdom |
| Employees | N/A | 66841 |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.6B | 108.7B |
| IPO Year | 2007 | N/A |
Fundamental Metrics
Financial Performance| Metric | DHR | GSK |
|---|---|---|
| Price | $176.80 | $51.88 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 2 |
| Target Price | ★ $241.69 | N/A |
| AVG Volume (30 Days) | ★ 3.6M | 3.6M |
| Earning Date | 04-21-2026 | 04-29-2026 |
| Dividend Yield | 0.89% | ★ 3.40% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.45 | N/A |
| Revenue | ★ $19,893,000,000.00 | N/A |
| Revenue This Year | $5.43 | $6.99 |
| Revenue Next Year | $5.74 | $4.19 |
| P/E Ratio | $125.37 | ★ $32.75 |
| Revenue Growth | ★ 8.53 | N/A |
| 52 Week Low | $160.93 | $35.45 |
| 52 Week High | $242.80 | $61.70 |
Technical Indicators
Market Signals| Indicator | DHR | GSK |
|---|---|---|
| Relative Strength Index (RSI) | 47.37 | 51.61 |
| Support Level | $175.00 | $51.55 |
| Resistance Level | $198.50 | $59.97 |
| Average True Range (ATR) | 4.52 | 0.80 |
| MACD | 0.05 | 0.29 |
| Stochastic Oscillator | 25.26 | 68.55 |
Price Performance
Historical ComparisonAbout DHR Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.